Your search for bevacizumab returned 5 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

News remove
Drugs in the Pipeline remove

Your search for bevacizumab returned 5 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Phase 3 study of Avastin for the treatment of ovarian cancer

Genentech announced results from its Phase 3 study of Avastin (bevacizumab) in combination with chemotherapy (carboplatin and gemcitabine) for the treatment of previously treated (recurrent), platinum-sensitive ovarian cancer.
Drugs in the Pipeline

Phase 3 study of perifosine for metastatic colon cancer

Æterna Zentaris and Keryx Biopharmaceuticals announced agreement with the FDA regarding a Special Protocol Assessment on its Phase 3 trial for perifosine (KRX-0401) for the treatment of refractory metastatic colorectal cancer.
Drugs in the Pipeline

Phase 3 study of Avastin for early stage breast cancer enrollment suspended

Roche announced the suspension of enrollment by the National Cancer Institute and US Eastern Cooperative Oncology Group (ECOG) for a Phase 3 study of Avastin (bevacizumab, from Roche and Genentech) in combination with chemotherapy in women with early-stage breast cancer.
Drugs in the Pipeline

Phase 3 study of Avastin for colon cancer

Genentech announced that its Phase 3 study of Avastin (bevacizumab) plus chemotherapy following surgery in patients with early-stage colon cancer did not meet its primary endpoint of improvement in disease-free survival.